-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/future05-breastcancer-10-5-2010final.pdf
September 01, 2010 - questionnaire
(100%)
5 were sent taped
Webinar and
questionnaire
10 refused (25%)
• 7 Unavailable: schedule … Reasons for refusal included: not interested in the project (2), unavailable due to a
vacation/schedule
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/breast-cancer-risk-reduction_research.pdf
October 25, 2010 - questionnaire
(100%)
5 were sent taped
Webinar and
questionnaire
10 refused (25%)
• 7 Unavailable: schedule … 12
Reasons for refusal included: not interested in the project (2), unavailable due to a
vacation/schedule
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/osteoarthritis-pain-2006_appendixes.pdf
January 01, 2006 - Comparative Effectiveness Review
118
Appendix A. Pharmacokinetics, Indications and
Dosing of Included Drugs
Drug and Trade
Name
(Trade names
provided only for
drugs under
patent.)
Half-life or other
relevant
pharmacokinetic
feature
Labeled indications Dosing (oral
doses)
Dose adjustments fo…
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/obesity-horizon-scan-high-impact-1506.pdf
June 01, 2015 - most requiring the use of a coupon.61 Based on recommended
dosing, after the 5-week dose-escalation schedule
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/disabilities-quality-improvement-outcomes_disposition-comments.pdf
October 15, 2012 - APTA
Introduction APTA suggests that the use of the World Health Organization
Disability Assessment Schedule
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/hepatitis-c-treatment-adherence_disposition-comments.pdf
December 20, 2012 - adherence will be an even greater challenge during triple
therapy regimens given the complex dosing schedule
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/cad-women-diagnosis_executive.pdf
June 01, 2012 - 1
Comparative Effectiveness Review
Number 58
Noninvasive Technologies for the Diagnosis of
Coronary Artery Disease in Women
Executive Summary
Background
Cardiovascular disease is the leading
cause of mortality for women in the
United States.1 Coronary heart disease—
which includes coronary artery (or
atheroscl…
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/nursing-home-safety_disposition-comments.pdf
May 27, 2016 - on the major but often
overlooked inherent limitation in the majority of observation
instruments/schedules
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/urinary-incontinence-treatment_research-protocol.pdf
September 30, 2010 - diaries of daily dietary,
physical activities, urinary habits; pelvic floor muscle exercises;
voiding schedules
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/dementia-agitation-aggression_disposition-comments.pdf
March 21, 2016 - However, a major limitation of
observational schedules is the fact that significant number of them … should be interpreted with this
fact in mind and a shift towards clinically relevant observational
schedules
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/osteoporosis-vibration-therapy_technical-brief.pdf
January 01, 2020 - or therapeutic
location, and in the home setting, where participants used the platform on their own schedule
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/mental-illness-adults-prisons_research-protocol.pdf
September 13, 2012 - Correctional facilities may not be designed to accommodate a variety
of medication administration schedules
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/lessons-transcript.pdf
January 06, 2017 - stakeholder input in projects with short
timelines or immediate start dates and it’s difficult to coordinate schedules
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/vte-prophyalaxis_research-protocol.pdf
March 01, 2011 - Evidence-based Practice Center Systematic Review Protocol
Source: www.effectivehealthcare.ahrq.gov
Published Online: January 12, 2012
Evidence-based Practice Center Systematic Review Protocol
Project Title: Comparative Effectiveness of Pharmacologic and Mechanical Prophylaxis
of Venous Thromboembolism …
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/prostate-cancer-test_research-protocol.pdf
October 14, 2011 - 1
Source: www.effectivehealthcare.ahrq.gov
Published Online: October 14, 2011
Evidence-based Practice Center Systematic Review Protocol
Project Title: PCA3 Testing for the Diagnosis and Management of Prostate
Cancer
I. Background and Objectives
Prostate cancer is the second most common cancer in ma…
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/depression-postpartum-screening_executive.pdf
May 01, 2013 - 1
Comparative Effectiveness Review
Number 106
Efficacy and Safety of Screening
for Postpartum Depression
Executive Summary
Background
Condition and Preventive Strategies
Depression is a potentially life-threatening
condition with a substantial impact on
quality of life. The impact of depression
in postpart…
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/surveillance-report-1-nonopioid-pharm-chronic-pain.pdf
April 01, 2022 - Systematic Review on Nonopioid Pharmacologic Treatments for Chronic Pain: Surveillance Report 1
Systematic Review on Nonopioid
Pharmacologic Treatments for Chronic
Pain: Surveillance Report 1
Literature Update Period: September 2019 through September 2021
Background and Purpose
This is the first update for the…
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/rapid-review-masks-prevention-covid-version-1.pdf
December 01, 2021 - Masks for Prevention of COVID-19 in Community and Healthcare Settings
Rapid Evidence Product
Version 1.0 (June 18, 2020)
Masks for Prevention of COVID-19 in
Community and Healthcare Settings
Background and Purpose
Currently, no proven treatments are available for coronavirus disease 2019 (COVID-19), the
dise…
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/rapid-review-masks-prevention-covid-version-2.pdf
December 01, 2021 - Rapid Evidence Product: Masks for Prevention of COVID-19 in Community and Healthcare Settings Version 2
Rapid Evidence Product
Version 2.0 (June 24, 2020)
Masks for Prevention of COVID-19 in
Community and Healthcare Settings
Background and Purpose
Currently, no proven treatments are available for coronavirus d…
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/registry-of-patient-registries-development_research_0.pdf
February 01, 2012 - the key stakeholders in health services
research and contacts these stakeholders (~150) on a regular schedule